Literature DB >> 11050470

The specific expression of three novel splice variant forms of human metalloprotease-like disintegrin-like cysteine-rich protein 2 gene inBrain tissues and gliomas.

T Harada1, A Nishie, K Torigoe, K Ikezaki, T Shono, Y Maehara, M Kuwano, M Wada.   

Abstract

We have previously identified 67 exons on a yeast artificial chromosome contig spanning 1.5 Mb around the multidrug resistance 1 gene region of human chromosome 7q21.1. In this study, we identified three novel cytoplasmic variants (MDC2-gamma, MDC2-delta, and MDC2-epsilon) of the human metalloprotease-like disintegrin-like cysteine-rich protein 2 (MDC2) among these exons by screening a human brain cDNA library and also by using a reverse transcription polymerase chain reaction. Genomic sequence analysis strongly supported the idea that the variations in the cytoplasmic domain were generated by alternative splicing. The expression of MDC2 variant forms in human brain tissue and gliomas was examined by reverse transcription polymerase chain reaction and RNase protection assay. MDC2-epsilon was expressed only in the cortical and hippocampal regions in human brain, but not in gliomas. In contrast, MDC2-gamma was a major form expressed in human gliomas. Specific expression of these cytoplasmic variants of MDC2 in human brain and its malignancies is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050470      PMCID: PMC5926265          DOI: 10.1111/j.1349-7006.2000.tb00877.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  21 in total

Review 1.  ADAMs: focus on the protease domain.

Authors:  R A Black; J M White
Journal:  Curr Opin Cell Biol       Date:  1998-10       Impact factor: 8.382

2.  Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha.

Authors:  M L Moss; S L Jin; M E Milla; D M Bickett; W Burkhart; H L Carter; W J Chen; W C Clay; J R Didsbury; D Hassler; C R Hoffman; T A Kost; M H Lambert; M A Leesnitzer; P McCauley; G McGeehan; J Mitchell; M Moyer; G Pahel; W Rocque; L K Overton; F Schoenen; T Seaton; J L Su; J D Becherer
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

3.  U1-mediated exon definition interactions between AT-AC and GT-AG introns.

Authors:  Q Wu; A R Krainer
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

4.  Recognition of unique carboxyl-terminal motifs by distinct PDZ domains.

Authors:  Z Songyang; A S Fanning; C Fu; J Xu; S M Marfatia; A H Chishti; A Crompton; A C Chan; J M Anderson; L C Cantley
Journal:  Science       Date:  1997-01-03       Impact factor: 47.728

5.  Localization of 67 exons on a YAC contig spanning 1.5 Mb around the multidrug resistance gene region of human chromosome 7q21.1.

Authors:  K Torigoe; T Harada; H Kusaba; T Uchiumi; K Kohno; E D Green; S W Scherer; L C Tsui; D Schlessinger; M Kuwano; M Wada
Journal:  Genomics       Date:  1998-04-01       Impact factor: 5.736

Review 6.  Splicing of messenger RNA precursors.

Authors:  R A Padgett; P J Grabowski; M M Konarska; S Seiler; P A Sharp
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

7.  Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases.

Authors:  F A Gonzalez; D L Raden; R J Davis
Journal:  J Biol Chem       Date:  1991-11-25       Impact factor: 5.157

8.  A novel metalloprotease/disintegrin-like gene at 17q21.3 is somatically rearranged in two primary breast cancers.

Authors:  M Emi; T Katagiri; Y Harada; H Saito; J Inazawa; I Ito; F Kasumi; Y Nakamura
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

9.  Human metalloprotease/disintegrin-like (MDC) gene: exon-intron organization and alternative splicing.

Authors:  T Katagiri; Y Harada; M Emi; Y Nakamura
Journal:  Cytogenet Cell Genet       Date:  1995

10.  Epilepsy and neuron loss in the hippocampus.

Authors:  A M Dam
Journal:  Epilepsia       Date:  1980-12       Impact factor: 5.864

View more
  4 in total

1.  ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.

Authors:  Susobhan Sarkar; Franz J Zemp; Donna Senger; Stephen M Robbins; V Wee Yong
Journal:  Neuro Oncol       Date:  2015-02-01       Impact factor: 12.300

2.  Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice.

Authors:  Koji Sagane; Kazuhiro Hayakawa; Junko Kai; Tomoko Hirohashi; Eiki Takahashi; Norimasa Miyamoto; Mitsuhiro Ino; Tohru Oki; Kazuto Yamazaki; Takeshi Nagasu
Journal:  BMC Neurosci       Date:  2005-05-06       Impact factor: 3.288

Review 3.  Metalloproteinases in biology and pathology of the nervous system.

Authors:  V W Yong; C Power; P Forsyth; D R Edwards
Journal:  Nat Rev Neurosci       Date:  2001-07       Impact factor: 34.870

4.  Dysfunctional ADAM22 implicated in progressive encephalopathy with cortical atrophy and epilepsy.

Authors:  Mikko Muona; Yuko Fukata; Anna-Kaisa Anttonen; Anni Laari; Aarno Palotie; Helena Pihko; Tuula Lönnqvist; Leena Valanne; Mirja Somer; Masaki Fukata; Anna-Elina Lehesjoki
Journal:  Neurol Genet       Date:  2016-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.